Comment on article: “Neutrophil-to-lymphocyte ratio as a serum biomarker associated with community acquired pneumonia”
Main Article Content
Keywords
Pneumonia, Neutrophils, B-Lymphocytes, Coronavirus Infections
Abstract
Identify in a timely manner, through the neutrophil / lymphocyte index, the severity of patients with pneumonia, including that produced by COVID-19, to improve the surveillance-treatment process towards therapeutic success.
References
Che-Morales JL, Cortes-Telles A. Índice neutrófilo/linfocito como biomarcador sérico asociado con neumonía adquirida en comunidad. Rev Med Inst Mex Seguro Soc. 2018;56(6):537-43.
Wan J, Wang X, Zhen Y, Chen X, Yao P, Liu W, et al. The predictive role of the neutrophil–lymphocyte ratio in the prognosis of adult patients with stroke. Chin Neurosurg J. 2020;6:22. DOI: 10.1186/s41016-020-00201-5
Ye W, Chen G, Li X, Lan X, Ji C, Hou M, et al. Dynamic changes of D-dimer and neutrophil-lymphocyte count ratio as prognostic biomarkers in COVID-19. Respir Res. 2020;21:169. DOI: 10.1186/s12931-020-01428-7
Imran MM, Ahmad U, Usman U, Ali M, Shaukat A, Gul N. Neutrophil/lymphocyte ratio- A marker of COVID-19 pneumonia severity. Int J Clin Pract. 2021;00:e13698. DOI: 10.1111/ijcp.13698
Stojkovic LM, Pavlovic MA, Stankovic S, Stojkovic M, Dimitrijevic I, Radoman IV, et al. Combined Diagnostic Efficacy of Neutrophil-to-Lymphocyte Ratio (NLR), Platelet-to-Lymphocyte Ratio (PLR), and Mean Platelet Volume (MPV) as Biomarkers of Systemic Inflammation in the Diagnosis of Colorectal Cancer. Disease Markers. 2019;2019: 7 pages. DOI: 10.1155/2019/6036979
Article Sidebar
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Authors retain their copyright and grant the Revista Médica del IMSS the right of first publication. Articles are distributed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which allows sharing as long as the author and the original source are properly credited.